Drug Profile
Research programme: monoclonal antibody biosimilars - Daewoong Pharmaceuticals
Alternative Names: DWP-438Latest Information Update: 06 Sep 2013
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer